According to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...
Executive Summary Azacitidine Market Size and Share Across Top Segments
CAGR Value
The global azacitidine market was valued at USD 90.24 billion in 2024 and is expected to reach USD 165.79 billion by 2032During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 7.90%, primarily driven by increasing geriatric population
By utilizing few steps or a number of...
About SPORTIVO Network
Czech
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek